Medimmune Limited

Andrew Buchanan

Philip Newton

Feenagh Keyes

Sven Nylander

Mark Penney

Tord Inghardt

The disclosure generally provides antibodies and antigen binding fragments of antibodies that bind ticagrelor and metabolites of ticagrelor. The disclosure also provides compositions comprising the antibodies, nucleic acid molecules encoding the antibodies, methods of treating a patient comprising administering the antibodies, and methods of making and using the antibodies.

Growing community of inventors

Cambridge, United Kingdom

Andrew Buchanan